MBA in Biotechnology
23-24 years old
10 Months. Full Time
None to 2 years
> 15 Nationalities
96% of the students within the year
The objective of the master program is to understand the process of how the industry prepares a new global drug approval entry and the global value dossier to work with the administrations and governments to deliver it to the patients
The main roles and companies related with these areas of knowledge’s are those such as, global and local market access manager, government affairs, pricing and value management or patient advocacy, among other corporate positions at biotechnology-based companies, the pharmaceutical industry and other companies related to healthcare.
Some of the areas of knowledge that will be develop during the MBA in Global Market Access involve, Premium Price and Shared risks, Real World Evidence, Price Negotiations, Reference Pricing & Pricing Strategy, Strategic market access - HTA and Government Affairs.
The Sc.MBA in Global Market Access will allow our studetns to have and applied understanding of the processes involved in new drug approvals and the relationship with the national governments in order to introduce new drugs for patients
Nerea Blanqué - Vice President Market Access and Pricing at Alira Health
The Sc.MBA in Global Market Access has allowed me to increase my specific knoweldge in the new drug approvals scene and has given me the tools to continue developing my career in this particular field
Maria Cavaller - Patient Engagement at EURORDIS - Rare Diseases Europe & BBI Alumni
"The master gave me a vision of the whole drug lifecycle, from early development stages until it is launched to the market. BBI also helped me to develop the necessary skills to work in the healthcare sector and, consequently, successfully start my career. "
Marta Aguado - HEOR Analyst at AliraHeatlh